← Open Payments lookup

ANDREW MISCOVICH: Open Payments

NPI 1023786431 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$788 in 39 payments from 8 companies in 2025. Trend: 2023 $140 · 2024 $636 · 2025 $788

Food & beverage: $788
CompanyPaymentsAmount
ABBVIE INC.19$330
AstraZeneca Pharmaceuticals LP5$137
Vanda Pharmaceuticals Inc.4$115
Novo Nordisk Inc4$70
Alexion Pharmaceuticals, Inc.2$44
Boehringer Ingelheim Pharmaceuticals, Inc.2$39
VERTEX PHARMACEUTICALS INCORPORATED2$36
Exact Sciences Corporation1$18

Products named: VRAYLAR, AIRSUPRA, FANAPT, UBRELVY, Wegovy, JARDIANCE, JOURNAVX, PONVORY.

Industry payments across WA — which companies pay providers there.